AbbVie Inc. (ABBV)
AbbVie Stock Falls Sharply as Schizophrenia Therapy Shows No ‘Significant' Improvement
Two trials of the company's experimental schizophrenia drug show no significant improvement in symptoms.
AbbVie's schizophrenia drug misses main goals of two trials
AbbVie said on Monday its experimental schizophrenia drug failed to meet the main goal of two mid-stage trials, sending its shares down more than 11% in premarket trading.
3 Spectacular High-Yield Dividend Stocks to Buy in November
High yields aren't a warning indicator with these three stocks.
My Favorite Dividend King to Buy in November
This Dividend King truly wears the crown.
Wall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Top 3 stocks to buy after Fed's 25-basis-point rate cut
US stocks remain resilient following the Federal Reserve's decision to lower its key interest rate by another 25 basis points on Thursday. According to the post-meeting statement: The Committee judges that the risks of achieving its employment and inflation goals are roughly in balance.
2 Dividend Kings That Would Have Doubled Your Money in 5 Years
You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.
Dividend Watch: Three Companies Boosting Quarterly Payouts
Earnings season continues to move at a rapid pace, with many companies reporting daily. And recently, these three companies delivered news of higher dividend payouts.
Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
High-Yield AbbVie Gains Momentum: A 20% Upside Is in Sight
The story with AbbVie NYSE: ABBV in 2024 is that it fell off a patent cliff but survived. It survived and continues to thrive because of its strengths in its core immunology portfolio and diversification efforts.
5 Stocks That Recently Announced Dividend Hikes
Investors may keep a tab on stocks like COP, BERY, HII, ABBV and ASB, which have lately hiked their dividend payments.
5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
It's hard to beat the power of dividend-paying stocks. They have outperformed non-payers significantly.
